Cross-disciplinary collaboration in connective tissue disease-related lung disease

Seminars in Respiratory and Critical Care Medicine

Volumn 35, Issue 2, 2014, Pages 159-165

  Fischer, Aryeh ^a   Richeldi, Luca ^b  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

collagen vascular disease; connective tissue disease; interstitial lung disease

Indexed keywords

ANTI RIBONUCLEOPROTEIN; ANTI TOPOISOMERASE; ANTI TRNA SYNTHETASE ANTIBODY; ANTI U3 RIBONUCLEOPROTEIN; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CENTROMERE ANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; NUCLEOLAR ANTINUCLEAR ANTIBODY; RHEUMATOID FACTOR; RIBONUCLEOPROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; DEMOGRAPHY; DISEASE SEVERITY; HISTOPATHOLOGY; HUMAN; INTERSTITIAL LUNG DISEASE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; COMPLICATION; COOPERATION; INTERDISCIPLINARY COMMUNICATION; LUNG DISEASES, INTERSTITIAL; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; TIME;

AUTOANTIBODIES; CONNECTIVE TISSUE DISEASES; COOPERATIVE BEHAVIOR; HUMANS; INTERDISCIPLINARY COMMUNICATION; LUNG DISEASES, INTERSTITIAL; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84897083034     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0034-1371530     Document Type: Article

References (34)

1. Fischer A., du Bois R. Interstitial lung disease in connective tissue disorders. Lancet: 2012; 380 (9842): 689 698
2. Fischer A., du Bois R. M. A Practical Approach to Connective Tissue Disease-Associated Lung Disease. 2nd ed. New York Springer: 2012
3. Frankel S. K., Brown K. K. Collagen vascular diseases of the lung. Clin Pulm Med: 2006; 13 1 25 36 (Pubitemid 43119757)
4. Olson A. L., Brown K. K. Connective tissue disease-associated lung disorders. Eur Resp Mon: 2009; 46 225 250
5. Steen V. D. The lung in systemic sclerosis. J Clin Rheumatol: 2005; 11 1 40 46 (Pubitemid 40223879)
6. Swigris J. J., Fischer A., Gillis J., Meehan R. T., Brown K. K. Pulmonary and thrombotic manifestations of systemic lupus erythematosus. Chest: 2008; 133 1 271 280
7. Cottin V. Interstitial lung disease: are we missing formes frustes of connective tissue disease? Eur Respir J: 2006; 28 5 893 896 (Pubitemid 46331953)
8. Doyle T. J., Hunninghake G. M., Rosas I. O. Subclinical interstitial lung disease: why you should care. Am J Respir Crit Care Med: 2012; 185 11 1147 1153
9. American Thoracic Society; European Respiratory Society American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med: 2002; 165 2 277 304
10. Park J. H., Kim D. S., Park I. N., et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med: 2007; 175 7 705 711
11. Kim E. J., Elicker B. M., Maldonado F., et al. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J: 2010; 35 6 1322 1328
12. Lee H. K., Kim D. S., Yoo B., et al. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest: 2005; 127 6 2019 2027
13. Bouros D., Wells A. U., Nicholson A. G., et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med: 2002; 165 12 1581 1586 (Pubitemid 34693935)
14. Kim D. S., Yoo B., Lee J. S., et al. The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis: 2002; 19 2 121 127 (Pubitemid 34685911)
15. Fischer A., Swigris J. J., du Bois R. M., et al. Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia. Respir Med: 2009; 103 11 1719 1724
16. Kowal-Bielecka O., Kowal K., Highland K. B., Silver R. M. Bronchoalveolar lavage fluid in scleroderma interstitial lung disease: technical aspects and clinical correlations: review of the literature. Semin Arthritis Rheum: 2010; 40 1 73 88
17. Silver R. M., Miller K. S., Kinsella M. B., Smith E. A., Schabel S. I. Evaluation and management of scleroderma lung disease using bronchoalveolar lavage. Am J Med: 1990; 88 5 470 476 (Pubitemid 20168722)
18. Strange C., Bolster M. B., Roth M. D., et al. Scleroderma Lung Study Research Group. Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease. Am J Respir Crit Care Med: 2008; 177 1 91 98
19. Goh N. S., Veeraraghavan S., Desai S. R., et al. Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression. Arthritis Rheum: 2007; 56 6 2005 2012 (Pubitemid 47110399)
20. Antoniou K. M., Margaritopoulos G., Economidou F., Siafakas N. M. Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement. Eur Respir J: 2009; 33 4 882 896
21. Mittoo S., Gelber A. C., Christopher-Stine L., Horton M. R., Lechtzin N., Danoff S. K. Ascertainment of collagen vascular disease in patients presenting with interstitial lung disease. Respir Med: 2009; 103 8 1152 1158
22. Fischer A., Pfalzgraf F. J., Feghali-Bostwick C. A., et al. Anti-th/to-positivity in a cohort of patients with idiopathic pulmonary fibrosis. J Rheumatol: 2006; 33 8 1600 1605 (Pubitemid 44168833)
23. Fischer A., Meehan R. T., Feghali-Bostwick C. A., West S. G., Brown K. K. Unique characteristics of systemic sclerosis sine scleroderma-associated interstitial lung disease. Chest: 2006; 130 4 976 981 (Pubitemid 44583724)
24. Castelino F. V., Goldberg H., Dellaripa P. F. The impact of rheumatological evaluation in the management of patients with interstitial lung disease. Rheumatology (Oxford): 2011; 50 3 489 493
25. Corte T. J., Copley S. J., Desai S. R., et al. Significance of connective tissue disease features in idiopathic interstitial pneumonia. Eur Respir J: 2012; 39 3 661 668
26. Raghu G., Collard H. R., Egan J. J., et al. ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med: 2011; 183 6 788 824
27. Hwang J. H., Misumi S., Sahin H., Brown K. K., Newell J. D., Lynch D. A. Computed tomographic features of idiopathic fibrosing interstitial pneumonia: comparison with pulmonary fibrosis related to collagen vascular disease. J Comput Assist Tomogr: 2009; 33 3 410 415
28. Lynch D. A. Quantitative CT of fibrotic interstitial lung disease. Chest: 2007; 131 3 643 644 (Pubitemid 46446850)
29. Lynch D. A., Travis W. D., Müller N. L., et al. Idiopathic interstitial pneumonias: CT features. Radiology: 2005; 236 1 10 21 (Pubitemid 40861695)
30. Fukuoka J. LK. Practical Pulmonary Pathology. A Diagnostic Approach. 1st ed. Philadelphia, PA Churchill-Livingstone: 2005
31. Leslie K. O., Trahan S., Gruden J. Pulmonary pathology of the rheumatic diseases. Semin Respir Crit Care Med: 2007; 28 4 369 378 (Pubitemid 350194720)
32. Song J. W., Do K. H., Kim M. Y., Jang S. J., Colby T. V., Kim D. S. Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia. Chest: 2009; 136 1 23 30
33. Flaherty K. R., Colby T. V., Travis W. D., et al. Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. Am J Respir Crit Care Med: 2003; 167 10 1410 1415 (Pubitemid 36609727)
34. Fischer A., Brown K. K., Frankel S. K. Treatment of connective tissue disease related interstitial lung disease. Clin Pulm Med: 2009; 16 2 74 80